Pharmascience | Pharmaceutical Business Partnership

Business Partnership

Always Open for Business With Interested Partners

At Pharmascience, collaboration and partnership is the key to our success. We rely on our suppliers, development partners, licensors, and customers to help us bring new products to patients across the globe. We are always open to new ideas and opportunities from interested partners.

Paul J. Evans Vice President, Global Business Development & Portfolio

Please select the area below that best matches your inquiry and let’s start a conversation.

With some of Canada’s finest pharmaceutical development and manufacturing facilities and teams, we are a contract development or manufacturing partner of choice. We have the capacity, expertise, skills and experience to meet your needs. Talk to us about a potential partnership.

David Goodman, PhD Executive Chairman of the Board

Partnership Opportunities in Canada

Specialty Pharma / Brand Product Distribution

At Pendopharm, our mission to bring innovative products to Canadian patients is the driving force behind our partnering strategy. We offer the flexibility and timely decision-making of a smaller company, while providing the infrastructure and resources of a large pharmaceutical corporation.

Generic Product Out-licensing/ Co-development

As a leading Canadian generic company, Pharmascience provides drug product developers and manufacturers a full-service distribution / promotion platform that delivers national and international reach, patient support, and market share growth.

Trust Pharmascience as your partner of choice to effectively commercialize, develop and expand your product innovation and portfolio with the agility and adaptability for creative partnership models. Let us know if you want to discuss.

Technology Out-licensing

Pharmascience invests between C$40-50 million annually in R&D and has a strong manufacturing base. We are on the cutting edge of drug product formulation and manufacturing technology and seek collaborations that can support that aspiration.

Talk to us about how your technology can advance our mutual goals.

We seek Active Pharmaceutical Ingredient (API) Suppliers

The development and supply of high quality, value-driven APIs is critical in bringing affordable medicines to patients around the world. Pharmascience’s supply chain team wants to develop relationships with API suppliers that can help us achieve that mission.

International Partnership Opportunities

 

Pharmascience International is committed to expanding our high-quality product and service offerings worldwide, delivering an exceptional experience. We aim to bring high quality, Canadian medications to partners and patients worldwide, enabling international access to affordable, life-changing therapies.

Our expert team of global professionals delivers a generic & branded portfolio spanning over 300 molecules and critical therapeutic areas. Our capability includes primary care, specialty, sterile injectable products, and high-potency oral dose products. We deliver an extensive, high quality, and reliable supply capability.

Pharmascience International is your worldwide partner. Our global team of expert professionals reaches over 50 countries, providing healthcare partners and patients easy access to the highest quality medications. Global and regional commercial and operational experts are located in APAC, MEA, EU/CEE & LATAM to ensure we deliver a high level of in-market expertise and an exceptional customer experience.

Contact us to find out more about how we can work together!

Royalmount Biopharma Services

Bioanalytical Services

Royalmount Biopharma Services boasts a purpose-built, partially automated, state-of-the-art GLP certified and FDA inspected laboratory. This laboratory provides robust bioanalytical method development and validation for quantification of drugs and metabolites in biological fluids/tissues using LC/MS/MS technology. All data collected and reports meet the high standards of FDA and OECD GLP along with current EMA and FDA bioanalytical guidelines.

Impurity/Nitrosamine Testing Services

With quick turnaround times and the most effective LC/MS/MS test methods currently on the market, our FDA-audited, and GMP-compliant laboratory specializes in the detection and quantification of ultra-low levels of nitrosamine impurities in diverse and complex matrices. We offer customized method development and validation for Active Pharmaceutical Ingredients (APIs) and Drug Products (DP) to support risk assessments. This allows you to take appropriate actions to reduce and mitigate nitrosamine impurities in your APIs and DPs. Partnering with Royalmount Biopharma Services will ensure that you are fully compliant with the most recent FDA guidelines.

Contract Development & Manufacturing

CDMO Services – Contract Development and Manufacturing

Royalmount Biopharma Services has been offering specialized CDMO services for sterile injectable products since 2014. From its facilities near Montreal, the organization provides turnkey solutions in formulation, fill/finish, and packaging, covering every stage of development from preclinical to commercial manufacturing.

As one of the few FDA-approved facilities in North America with cytotoxic capabilities, its CDMO Services are equipped to meet the most complex needs. Through exclusive partnerships, CDMO services also support preclinical studies and clinical trials from Phase I to III.

The expansion of the Candiac facility, announced in 2023, will increase production capacity and broaden service offerings starting in 2026. The team supports the development and manufacturing of complex injectable drugs—including liquid vials, lyophilized vials, and prefilled syringes—with high-potency formulations.

Tailored services are also available for low-volume tablets and capsules, including extended-release and cytotoxic formulations, all in compliance with FDA, EMA, and Health Canada standards.

If you are interested to learn more about Royalmount Biopharma Services, please contact us.

Through Royalmount Labs, we wish to offer to our business partners the best-in-class expertise, skills and experience that has made Pharmascience a world-class generic manufacturer. We can support you with a broad range of small molecule bioanalytical services, including impurities testing (nitrosamine).

David Goodman, PhD Executive Chairman of the Board

Clinical Research

Pharmascience believes in supporting Clinical Investigators researching new uses of proven medications and performing novel research that brings new therapies to benefit patients.

Suppliers

Supplier Guidelines: This document provides guidelines to requirements for shipments destined for Pharmascience facilities.